FDA Inspection 1252187 — The Procter & Gamble Manufacturing Company

The Procter & Gamble Manufacturing Company — FEI 1913771

The FDA completed an inspection of The Procter & Gamble Manufacturing Company on September 27, 2024 in Iowa City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Iowa City, IA (United States)